Finished pharmaceutical products local manufacturing

Over 50 percent of pharmaceuticals are imported as finished products. Furthermore, many products are manufactured by local manufacturers under license from multinational companies. In 1997, 53 percent of products manufactured by the local industry were exported. Table 2 summarizes import/export data. 

The Indonesian pharmaceutical industry imports 95% of the pharmaceutical raw materials needed. Importation of finished products is not allowed, except for medical products not manufactured locally, for example insulin. There are 280 pharmaceutical manufacturers in Indonesia ... 

Most original and patented pharmaceuticals on the Israeli market are either imported as finished products or are manufactured locally under license from multinational pharmaceutical companies. The import of pharmaceuticals is restricted to the registration holder, with the exception of medical institutions importing for their own use. This provision actuedly prevents parallel import. However recent legislation requires opening the market to peirallel import, and present regulations in this respect will be amended. 

---